-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ASfmVeJIptV5sZu1eA2RP4SabQRd+rUYPLKSmr7uViaz2bW+RD6MXMvWYClyscuT cdB/7zKpqqddlYxihcayzQ== 0000950123-10-002799.txt : 20100115 0000950123-10-002799.hdr.sgml : 20100115 20100115104853 ACCESSION NUMBER: 0000950123-10-002799 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100115 DATE AS OF CHANGE: 20100115 GROUP MEMBERS: LINDEN CAPITAL LP GROUP MEMBERS: LINDEN GP LLC GROUP MEMBERS: SIU MIN WONG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VERENIUM CORP CENTRAL INDEX KEY: 0001049210 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 223297375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60329 FILM NUMBER: 10529203 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 674 5300 MAIL ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: DIVERSA CORP DATE OF NAME CHANGE: 19991201 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Linden Capital L.P. CENTRAL INDEX KEY: 0001349339 IRS NUMBER: 980430338 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 18 CHURCH STREET, SKANDIA HOUSE CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-294-3202 MAIL ADDRESS: STREET 1: 18 CHURCH STREET, SKANDIA HOUSE CITY: HAMILTON STATE: D0 ZIP: HM11 SC 13G/A 1 c94697sc13gza.htm SCHEDULE 13G/A Schedule 13G/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

Verenium Corporation
(Name of Issuer)
Common Stock
(Title of Class of Securities)
92340P100
(CUSIP Number)
December 31, 2009
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

(Continued on the Following Pages)
(Page 1 of 6 Pages)


 

                     
CUSIP No.
 
92340P100 
 

 

           
1   NAMES OF REPORTING PERSONS
Linden Capital LP
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Bermuda
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   40,313
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    40,313
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  40,313
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  Less than 1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 2 of 6


 

                     
CUSIP No.
 
92340P100 
 

 

           
1   NAMES OF REPORTING PERSONS
Linden GP LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   40,313
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    40,313
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  40,313
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  Less than 1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 3 of 6


 

                     
CUSIP No.
 
92340P100 
 

 

           
1   NAMES OF REPORTING PERSONS
Siu Min Wong
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   þ
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  China
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   40,313
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    40,313
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  40,313
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  Less than 1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN, HC

Page 4 of 6


 

This Amendment No. 1 (“Amendment No. 1”) is filed pursuant to Rule 13d-2(b) promulgated under the Securities Exchange Act of 1934, as amended, with respect to the shares of Common Stock, $.001 par value per share (the “Common Stock”), of Verenium Corporation (the “Issuer”) beneficially owned by the Reporting Persons specified herein as of December 31, 2009, and amends and supplements the Schedule 13G filed May 15, 2009 (collectively, the “Schedule 13G”). Except as set forth herein, the Schedule 13G is unmodified. This Amendment No. 1 takes into account the 1-for-12 reverse split of the Common Stock on September 9, 2009.
The names of the persons filing this statement on Amendment No. 1 are: Linden Capital LP, a Bermuda limited partnership (“Linden Capital”), Linden GP LLC, a Delaware limited liability company (“Linden GP”), and Siu Min Wong (“Mr. Wong,” and collectively, the “Reporting Persons”).
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
  (a)   Amount beneficially owned:
 
      The Reporting Persons collectively beneficially own warrants to purchase 40,313 shares of Common Stock.
 
  (b)   Percent of class:
 
      The Reporting Persons have beneficial ownership of shares constituting less than 1% of all of the outstanding shares of Common Stock.
 
  (c)   Number of shares as to which such person has:
  (i)   Sole power to vote or to direct the vote
      Not applicable.
  (ii)   Shared power to vote or to direct the vote
      Linden Capital, Linden GP and Mr. Wong have shared power to vote or direct the vote of the 40,313 shares of Common Stock held by Linden Capital.
  (iii)   Sole power to dispose or to direct the disposition of
      Not applicable.
  (iv)   Shared power to dispose or to direct the disposition of
      Linden Capital, Linden GP and Mr. Wong have shared power to dispose or direct the disposition of the 40,313 shares of Common Stock held by Linden Capital.

 

Page 5 of 6


 

Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ.
Item 10. Certification.
By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
Dated: January 15, 2010
         

LINDEN CAPITAL L.P.
 
   
By:   Linden GP LLC, general partner      
     
By:   /S/ Siu Min Wong      
  Siu Min Wong,      
  Managing Member     
 
LINDEN GP LLC
 
   
By:   /S/ Siu Min Wong      
  Siu Min Wong,    
  Managing Member     
 
     
/S/ Siu Min Wong      
SIU MIN WONG     
     
 

 

Page 6 of 6

-----END PRIVACY-ENHANCED MESSAGE-----